Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade

DOI: 10.1080/2162402X.2019.1571390

Keywords: Immunotherapy, MEK inhibition, Melanoma, Oncolytic virus, Programmed cell death 1 (PD-1)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text